Literature DB >> 15466484

Epigenetics and cancer.

Anders H Lund1, Maarten van Lohuizen.   

Abstract

Epigenetic mechanisms act to change the accessibility of chromatin to transcriptional regulation locally and globally via modifications of the DNA and by modification or rearrangement of nucleosomes. Epigenetic gene regulation collaborates with genetic alterations in cancer development. This is evident from every aspect of tumor biology including cell growth and differentiation, cell cycle control, DNA repair, angiogenesis, migration, and evasion of host immunosurveillance. In contrast to genetic cancer causes, the possibility of reversing epigenetic codes may provide new targets for therapeutic intervention. Copyright 2004 Cold Spring Harbor Laboratory Press

Entities:  

Mesh:

Year:  2004        PMID: 15466484     DOI: 10.1101/gad.1232504

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  143 in total

1.  Targeting the enhancer of zeste homologue 2 in medulloblastoma.

Authors:  Irina Alimova; Sujatha Venkataraman; Peter Harris; Victor E Marquez; Paul A Northcott; Adrian Dubuc; Michael D Taylor; Nicholas K Foreman; Rajeev Vibhakar
Journal:  Int J Cancer       Date:  2012-07-30       Impact factor: 7.396

2.  Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity.

Authors:  Marcel W Coolen; Clare Stirzaker; Jenny Z Song; Aaron L Statham; Zena Kassir; Carlos S Moreno; Andrew N Young; Vijay Varma; Terence P Speed; Mark Cowley; Paul Lacaze; Warren Kaplan; Mark D Robinson; Susan J Clark
Journal:  Nat Cell Biol       Date:  2010-02-21       Impact factor: 28.824

Review 3.  Epigenetic regulation of hematopoietic stem cell self-renewal by polycomb group genes.

Authors:  Atsushi Iwama; Hideyuki Oguro; Masamitsu Negishi; Yuko Kato; Hiromitsu Nakauchi
Journal:  Int J Hematol       Date:  2005-05       Impact factor: 2.490

Review 4.  The end adjusts the means: heterochromatin remodelling during terminal cell differentiation.

Authors:  Sergei A Grigoryev; Yaroslava A Bulynko; Evgenya Y Popova
Journal:  Chromosome Res       Date:  2006       Impact factor: 5.239

5.  Carcinogenesis and metastasis now in the third dimension--what's in it for pathologists?

Authors:  Carlos Sonnenschein; Ana M Soto
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

6.  Akt/PKB interacts with the histone H3 methyltransferase SETDB1 and coordinates to silence gene expression.

Authors:  Haidong Gao; Zhigang Yu; Dongsong Bi; Liyu Jiang; Yazhou Cui; Jingzhong Sun; Rong Ma
Journal:  Mol Cell Biochem       Date:  2007-06-19       Impact factor: 3.396

Review 7.  Epigenomics and breast cancer.

Authors:  Pang-Kuo Lo; Saraswati Sukumar
Journal:  Pharmacogenomics       Date:  2008-12       Impact factor: 2.533

8.  Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines.

Authors:  Margaret E McLaughlin-Drubin; Donglim Park; Karl Munger
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-17       Impact factor: 11.205

9.  Epigenetic control of the immune escape mechanisms in malignant carcinomas.

Authors:  A Francesca Setiadi; Muriel D David; Robyn P Seipp; Jennifer A Hartikainen; Rayshad Gopaul; Wilfred A Jefferies
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

10.  Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancer.

Authors:  Jian-Hua Luo; Ying Ding; Rui Chen; George Michalopoulos; Joel Nelson; George Tseng; Yan P Yu
Journal:  Am J Pathol       Date:  2013-04-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.